Authors
Latest:
Omid Hamid on Responses to Single Agent Immunotherapies Compared to CombinationOmid Hamid, MD, compares the responses of patients with melanoma on single-agent immunotherapy treatment to those on combination therapy treatments.
Latest:
Smita Bhatia on Treatment and Risk of Developing Other CancersSmita Bhatia, MD, MPH, discusses the relationship between treatment for cancer and the development of other cancers.
Latest:
Palliative Care: When Patients Understand It, They Are More Likely to Use ItA recent study determined that an education initiative could help to ease worries patients with cancer may have about palliative care, thus improving quality of life.
Latest:
Hackensack Meridian Health to Pilot Combined Watson for Oncology and Cota Technology to Power Value-Based Clinical Decision Support in Cancer CareIBM Watson Health, Cota and Hackensack Meridian Health have joined together to help oncologists make evidence- and outcomes-based clinical decisions for their cancer patients, which could reduce total cost of care.
Latest:
Screening Saves: Know Your Options And Talk to Your DoctorOn March 21, at 9 PM EST, the #CureConnect tweetchat will be focusing on screening and prevention. Sharyn Worrall, Patient Education Manager for FightCRC will be comoderating on this topic, which is especially important for colorectal cancer.
Latest:
Amelie Harle on Aprepitant's Effectiveness in Treating Cough in Lung CancerAmelie Harle, an oncologist at Christie Hospital in Manchester, United Kingdom, discusses the possibility of using aprepitant (Emend) to treat cough in patients with lung cancer.
Latest:
Transitioning Breast Cancer Survivors Back to Primary CareAfter being treated for breast cancer, nurse practitioners at MSK help survivors transition back to their primary care physicians.
Latest:
Expert Discusses Updates in Thyroid CancerThe past 10 years have shown significant updates for treatment of patients with thyroid cancer, beyond just targeted therapies.
Latest:
How Can We Help Patients Who Suffer from CIPN?Understanding the effects of chemotherapy-induced peripheral neuropathy (CIPN) is imperative to be able to care for our patients better.
Latest:
Immunotherapy: Personalized Treatment for Advanced Prostate CancerIn April 2010, the FDA approved sipuleucel-T for patients with castration-resistant and metastatic prostate cancer, providing a new treatment that would help the body fight its own cancer.
Latest:
Wounded Healers in Oncology NursingBy being aware of one’s own woundedness (including the wound of our mortality) we can be more effective healers in our work as healthcare professionals.
Latest:
Reach Out and Communicate with Your Psycho-Oncology Interdisciplinary TeamElizabeth Archer-Nanda, DNP, APRN, PMHCNS-BC, psychiatric nurse specialist at the Norton Cancer Institute, would like you to pick up the phone and call your cancer patient's oncologist to set aside just one hour to round with him or her and brainstorm how to help your patient have the best possible quality of life.
Latest:
Jonathan Schoenfeld Answers: Which Patients Benefit Most from Immunotherapy and RadiationJonathan Schoenfeld discusses the patient profile that would benefit best from a combination of radiation and immunotherapy.
Latest:
Choosing an Iron Chelation Therapy for a Patient with MDSPhyllis McKiernan, MSN, APN, OCN, Blood & Marrow Transplant Program, John Theurer Cancer Center explains factors that go into choosing an iron chelation therapy for a patient with myelodisplastic syndrome (MDS) experiencing transfusion-related iron overload.
Latest:
Potential Expansion for TTFields into Treating Grade III Brain TumorsAn upcoming study hopes to expand the use of tumor treating fields (TTFields) from only glioblastoma (grade IV tumors) into also treating grade III anaplastic astrocytomas as well.
Latest:
Jackie Miller Provides an Overview of Virtua's Camp OasisJackie Miller, RN, BSN, OCN, nurse navigator, Virtua Fox Chase Cancer Program, provides an overview of a day of fun, support and education for children and teens who have a loved one with cancer.
Latest:
Comparing CVD Risk Factors Associated With Adjuvant Endocrine TherapiesA retrospective analysis conducted by researchers at Kaiser Permanente and UCLA has concluded that patients with breast cancer treated with aromatase inhibitors (AIs) as adjuvant endocrine therapy were at equal risk of serious cardiovascular disease (CVD) events as those treated with tamoxifen.
Latest:
Impact of Goals of Care on Resource Use at End of LifeResearchers exam­ined whether there were differences in resource use at end of life between patients with advanced cancer who identified goals of care focused heavily upon survival versus those who identified goals of care heavily focused on quality of life.
Latest:
Providers Want Better Training on LGBTQ PopulationsOncology providers reported having limited knowledge of the special concerns of LGBTQ patients, but wanted to know more.
Latest:
Bypassing the SICU May Improve Patient OutcomesSmilow Cancer Hospital tested sending patients directly from the post–anesthesia care unit (PACU) to the surgical oncology unit after head and neck surgery to reduce length of stay, postoperative complications, and readmission rates of patients.
Latest:
Working Together for Optimal Patient CareNurses, other clinicians, and outside organizations must work together to ensure that all patients' needs and concerns are being addressed.
Latest:
Managing Constipation in the Cancer Care SettingAbout 60% of adult patients with cancer experience constipation, but oncology nurses can help.
Latest:
Adverse Events of CAR T-Cell TherapyIt is crucial for nurses to be aware of adverse events that can occur in patients who are receiving CAR T-cell therapy, explained one expert.
Latest:
Young People with GI Complaints Should Be Screened for Colon CancerJohn Marshall, MD, explains that health care providers need to retool their thinking when young people present with GI complaints, and be open to the possibility that these could indicate colon cancer.
Latest:
Jeffrey Jones Discusses Nurses' Impact on Patient ComplianceJeffrey Jones, MD, MPH, assistant professor of Internal Medicine and section head of the Chronic Lymphocytic Leukemia (CLL) research program at Ohio State University Comprehensive Cancer Center, discusses how nurses can help patients comply with taking their oncology drugs.
Latest:
Jennifer Smith Discusses Specialized Support for Veterans With CancerJennifer Smith, MSN, CNP, Louis Stokes Cleveland VA Medical Center, discusses specialized support for veterans with cancer.
Latest:
Distress During Radiation Therapy Linked to Missed Appointments and HospitalizationPatients with cancer who suffer severe distress are more likely to miss appointments during the course of their radiation therapy and be admitted to the hospital.
